Atrian Farzaneh, Ramirez Paulino, De Mange Jasmine, Marquez Marissa, Gonzalez Elias M, Minaya Miguel, Karch Celeste M, Frost Bess
Sam & Ann Barshop Institute for Longevity and Aging Studies, San Antonio, TX.
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, TX.
bioRxiv. 2024 Jan 26:2024.01.25.577211. doi: 10.1101/2024.01.25.577211.
Circular RNAs (circRNAs), covalently closed RNA molecules that form due to back-splicing of RNA transcripts, have recently been implicated in Alzheimer's disease and related tauopathies. circRNAs are regulated by N-methyladenosine (mA) RNA methylation, can serve as "sponges" for proteins and RNAs, and can be translated into protein via a cap-independent mechanism. Mechanisms underlying circRNA dysregulation in tauopathies and causal relationships between circRNA and neurodegeneration are currently unknown. In the current study, we aimed to determine whether pathogenic forms of tau drive circRNA dysregulation and whether such dysregulation causally mediates neurodegeneration. We identify circRNAs that are differentially expressed in the brain of a model of tauopathy and in induced pluripotent stem cell (iPSC)-derived neurons carrying a tau mutation associated with autosomal dominant tauopathy. We leverage to discover that depletion of circular forms of (, a circRNA that is particularly abundant in brains of tau transgenic , significantly suppresses tau neurotoxicity, suggesting that tau-induced elevation is neurotoxic. We detect a general elevation of mA RNA methylation and circRNA methylation in tau transgenic and find that tau-induced mA methylation is a mechanistic driver of formation. Interestingly, we find that circRNA and mA RNA accumulate within nuclear envelope invaginations of tau transgenic and in iPSC-derived cerebral organoid models of tauopathy. Taken together, our studies add critical new insight into the mechanisms underlying circRNA dysregulation in tauopathy and identify mA-modified circRNA as a causal factor contributing to neurodegeneration. These findings add to a growing literature implicating pathogenic forms of tau as drivers of altered RNA metabolism.
环状RNA(circRNAs)是由于RNA转录本的反向剪接而形成的共价闭合RNA分子,最近被认为与阿尔茨海默病及相关的tau蛋白病有关。circRNAs受N-甲基腺苷(mA)RNA甲基化调控,可作为蛋白质和RNA的“海绵”,并可通过一种不依赖帽子的机制翻译成蛋白质。目前尚不清楚tau蛋白病中circRNA失调的潜在机制以及circRNA与神经退行性变之间的因果关系。在本研究中,我们旨在确定tau蛋白的致病形式是否会导致circRNA失调,以及这种失调是否因果性地介导神经退行性变。我们鉴定了在tau蛋白病模型的大脑以及携带与常染色体显性tau蛋白病相关的tau突变的诱导多能干细胞(iPSC)衍生神经元中差异表达的circRNAs。我们利用这些发现,发现tau转基因小鼠大脑中特别丰富的一种circRNA——CiRS-7(也称为CDR1as)的环状形式的缺失显著抑制了tau蛋白的神经毒性,这表明tau诱导的CiRS-7升高具有神经毒性。我们检测到tau转基因小鼠中mA RNA甲基化和circRNA甲基化普遍升高,并发现tau诱导的mA甲基化是CiRS-7形成的机制驱动因素。有趣的是,我们发现circRNA和mA RNA在tau转基因小鼠的核膜内陷以及tau蛋白病的iPSC衍生脑类器官模型中积累。综上所述,我们的研究为tau蛋白病中circRNA失调的潜在机制提供了重要的新见解,并确定了mA修饰的circRNA是导致神经退行性变的一个因果因素。这些发现进一步丰富了越来越多的将tau蛋白的致病形式视为RNA代谢改变驱动因素的文献。